RxDoctor Payments DataLook up a doctor →

Radicava ORS: payments to doctors

Payments that named Radicava ORS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$405K
Providers
2,996
Transactions
7,931
Average per transaction
$51

The per-transaction average — $51 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,996 providers the average total is $135, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mitsubishi Tanabe Pharma America, Inc.$323,35479.9%
Tanabe Pharma America, Inc.$81,30420.1%
← All drugs & devices